Cabazitaxel
Who holds supplier records for Cabazitaxel? 14 organisations hold a current record for Cabazitaxel: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6), China (4), Italy (1) and Netherlands (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cabazitaxel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cabazitaxel
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Cabazitaxel expires 27 Apr 2031. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cabazitaxel. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 27831, 29364 · latest filing May 2015
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 27895 · latest filing Feb 2014
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 28159 · latest filing Apr 2014
- INDENA SPAItaly Company GMP cert on recordActive DMF 34809 · latest filing Apr 2020
- Intas Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 27978 · latest filing Feb 2014
- Jiangsu Xidi Pharmaceuticals Co., LtdChinaActive DMF 43007 · latest filing Dec 2025
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 28293 · latest filing Jun 2014
- Shandong Anhong Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 27441 · latest filing Sept 2013
- Shandong New Time Pharmaceutical Co LtdCompany GMP cert on recordActive DMF 39830 · latest filing May 2024
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 33087 · latest filing Jun 2020
- SICHUAN ELIXIR PHARMACEUTICAL CO LTDActive DMF 39645 · latest filing Mar 2024
- Sichuan Xieli Pharmaceutical Co LtdChinaActive DMF 26462 · latest filing Sept 2012
- TAPI NL BVNetherlandsActive DMF 28101 · latest filing Apr 2014
- Tianjin Weijie Pharmaceutical Co., Ltd.ChinaActive DMF 31137 · latest filing Dec 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Cabazitaxel are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- POLYMED THERAPEUTICS INCInactive DMF 25769 · filed Feb 2012
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (3 listed products contain Cabazitaxel). The latest listed patent expires 27 Apr 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Cabazitaxel is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201748).
Chemical identity
- IUPAC name
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- Canonical SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC
- InChIKey
- BMQGVNUXMIRLCK-OAGWZNDDSA-N
- Synonyms
- Cabazitaxel, Cabazitaxel accord, Cabazitaxel acetonate, Jevtana, Jevtana kit, NSC-761432, TXD 258, TXD-258, TXD258, XRP 6258, XRP-6258, XRP6258
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cabazitaxel?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Cabazitaxel: MSN Laboratories Private Limited (India), Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), INDENA SPA (Italy), Intas Pharmaceuticals Ltd. (India), Jiangsu Xidi Pharmaceuticals Co., Ltd (China), Laurus Labs Limited (India) and Shandong Anhong Pharmaceutical Co., Ltd. (China), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cabazitaxel Drug Master Files are active?
MSN Laboratories Private Limited (DMF 27831, 29364), Dr. Reddy's Laboratories Ltd. (DMF 27895), Hetero Labs Limited (DMF 28159), INDENA SPA (DMF 34809), Intas Pharmaceuticals Ltd. (DMF 27978), Jiangsu Xidi Pharmaceuticals Co., Ltd (DMF 43007), Laurus Labs Limited (DMF 28293) and Shandong Anhong Pharmaceutical Co., Ltd. (DMF 27441) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cabazitaxel records mean?
1 organisation has only inactive Type II DMFs for Cabazitaxel. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Cabazitaxel?
Yes. The latest patent listed for an approved US product containing Cabazitaxel expires 27 Apr 2031, across 3 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Cabazitaxel supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cabazitaxel?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.